deflazacort

Showing 1 posts of 1 posts found.

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016
Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …

The Gateway to Local Adoption Series

Latest content